Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 22204-53-1
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
22204-53-1 |
Appearance:: |
White Crystal Or Crystalline Powder |
Molecular Formula:: |
C14H14O3 |
Molecular Weight:: |
230.25900 |
EINECS NO:: |
244-838-7 |
MDL NO:: |
MFCD00010500 |
CAS NO:: |
22204-53-1 |
Appearance:: |
White Crystal Or Crystalline Powder |
Molecular Formula:: |
C14H14O3 |
Molecular Weight:: |
230.25900 |
EINECS NO:: |
244-838-7 |
MDL NO:: |
MFCD00010500 |
Product Description:
Product Name: Naproxen CAS NO: 22204-53-1
Synonyms:
(2S)-2-(6-metho-xynaphthalen-2-yl)propanoic acid;
(S)-(+)-6-Metho-xy-α-methyl-2-naphthaleneacetic Acid;
(S)-(+)-2-(6-Metho-xy-2-naphthyl)propionic Acid;
Chemical & Physical Properties:
Appearance: White crystal or crystalline powder
Assay :≥99.00%
Density: 1.197g/cm3
Boiling Point: 403.9℃ at 760mmHg
Melting Point: 153-154℃
Flash Point: 154.5℃
Refractive Index: 67.5 ° (C=1, CHCl3)
Storage Condition: Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Vapor Pressure: 3.01E-07mmHg at 25℃
Safety Information:
RTECS: UF5275000
Hazard Class: 6.1(b)
Safety Statements: S36/37
HS Code: 2916399090
WGK Germany: 3
Packing Group: III
RIDADR: UN 2811
Risk Statement: R22
Hazard Code: Xn
Signal Word: Danger
Hazard Declaration: H301
Symbol: GHS06
Naproxen (brand names: Aleve, Naprosyn, and many others) is a nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class (the same class as ibuprofen) that relieves pain, fever, swelling, and stiffness.:665,673 It is a nonselective COX inhibitor, usually sold as the sodium salt.
It is the preferred NSAID for long-term use in people with a high risk of cardiovascular complications (for example, heart attacks or strokes),:665 due to its relatively low risk of such complications. Naproxen poses an intermediate risk of stomach ulcers compared to ibuprofen, which is low-risk, and indometacin, which is high-risk. To reduce stomach ulceration risk, it is often combined with a proton-pump inhibitor (a medication that reduces stomach acid production) during long-term treatment of those with pre-existing stomach ulcers or a history of developing stomach ulcers while on NSAIDs.:665,673. Being analogous to other drugs of this series, naproxene exhibits analgesic, fever-reduc[1]ing, and long-lasting anti-inflammatory action. It causes reduction and removal of painful symptoms including joint pain, stiffness, and swelling in the joints. It is used in the same indications as ibuprofen.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.